Liu M, Wang W, Wang Y
Front Med (Lausanne). 2024; 11:1391621.
PMID: 39314227
PMC: 11416989.
DOI: 10.3389/fmed.2024.1391621.
Li K, Meng M, Zhang W, Li J, Wang Y, Zhou C
Front Oncol. 2024; 14:1370709.
PMID: 38651158
PMC: 11033366.
DOI: 10.3389/fonc.2024.1370709.
Bernet L, Hardisson D, Rodrigo M, Cordoba A, Sancho M, Peg V
Clin Pathol. 2023; 16:2632010X231183693.
PMID: 37534372
PMC: 10392164.
DOI: 10.1177/2632010X231183693.
Vieites B, Lopez-Garcia M, Martin-Salvago M, Ramirez-Tortosa C, Rezola R, Sancho M
Clin Transl Oncol. 2021; 23(7):1377-1385.
PMID: 33517542
PMC: 8192368.
DOI: 10.1007/s12094-020-02530-4.
Ramirez-Exposito M, Urbano-Polo N, Duenas B, Navarro-Cecilia J, Ramirez-Tortosa C, Martin-Salvago M
Ups J Med Sci. 2017; 122(4):207-216.
PMID: 29264992
PMC: 5810224.
DOI: 10.1080/03009734.2017.1403522.
One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis.
Shi F, Zhang Q, Liang Z, Zhang M, Liu X
Br J Cancer. 2017; 117(8):1185-1191.
PMID: 28797030
PMC: 5674095.
DOI: 10.1038/bjc.2017.262.
Association of One-Step Nucleic Acid Amplification Detected Micrometastases with Tumour Biology and Adjuvant Chemotherapy.
Goussous G, Jafferbhoy S, Smyth N, Hammond L, Narayanan S, Kirby R
Int J Breast Cancer. 2017; 2017:4971096.
PMID: 28695012
PMC: 5485356.
DOI: 10.1155/2017/4971096.
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
Terrenato I, DAlicandro V, Casini B, Perracchio L, Rollo F, De Salvo L
PLoS One. 2017; 12(2):e0171517.
PMID: 28187209
PMC: 5302783.
DOI: 10.1371/journal.pone.0171517.
Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.
Rakislova N, Montironi C, Aldecoa I, Fernandez E, Bombi J, Jimeno M
J Transl Med. 2017; 15(1):14.
PMID: 28088238
PMC: 5237515.
DOI: 10.1186/s12967-016-1114-3.
Intraoperative diagnosis of sentinel lymph node metastases in breast cancer treatment with one-step nucleic acid amplification assay (OSNA).
Szychta P, Westfal B, Maciejczyk R, Smolarz B, Romanowicz H, Krawczyk T
Arch Med Sci. 2016; 12(6):1239-1246.
PMID: 27904514
PMC: 5108387.
DOI: 10.5114/aoms.2016.62902.
One-step nucleic acid amplification (OSNA): where do we go with it?.
Tamaki Y
Int J Clin Oncol. 2016; 22(1):3-10.
PMID: 27549784
DOI: 10.1007/s10147-016-1030-9.
Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
Martin-Sanchez E, Pernaut-Leza E, Mendaza S, Cordoba A, Vicente-Garcia F, Monreal-Santesteban I
Virchows Arch. 2016; 469(1):51-9.
PMID: 27097811
DOI: 10.1007/s00428-016-1941-x.
Sentinel lymph nodes for breast carcinoma: an update on current practice.
Maguire A, Brogi E
Histopathology. 2016; 68(1):152-67.
PMID: 26768036
PMC: 5027880.
DOI: 10.1111/his.12853.
Clinical significance of breast cancer micrometastasis in the sentinel lymph node.
Shimazu K, Noguchi S
Surg Today. 2015; 46(2):155-60.
PMID: 25893770
DOI: 10.1007/s00595-015-1168-5.
OSNA (one-step nucleic acid amplification) sentinel lymph node intraoperative molecular analysis in breast cancer: a cost-benefit analysis.
Raia-Barjat T, Trombert B, Khaddage A, Douchet C, Seffert P, Peoch M
Med Oncol. 2014; 31(12):322.
PMID: 25416045
DOI: 10.1007/s12032-014-0322-z.
The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.
Giammarile F, Alazraki N, Aarsvold J, Audisio R, Glass E, Grant S
Eur J Nucl Med Mol Imaging. 2013; 40(12):1932-47.
PMID: 24085499
DOI: 10.1007/s00259-013-2544-2.
Intra-operative use of one-step nucleic acid amplification (OSNA) for detection of the tumor load of sentinel lymph nodes in breast cancer patients.
Heilmann T, Mathiak M, Hofmann J, Mundhenke C, van Mackelenbergh M, Alkatout I
J Cancer Res Clin Oncol. 2013; 139(10):1649-55.
PMID: 23907595
DOI: 10.1007/s00432-013-1481-6.
One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis.
Pegolo E, Puppin C, Gerometta A, Damante G, Puglisi F, Di Loreto C
Virchows Arch. 2013; 463(1):7-15.
PMID: 23779101
DOI: 10.1007/s00428-013-1440-2.
Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.
Buglioni S, Di Filippo F, Terrenato I, Casini B, Gallo E, Marandino F
PLoS One. 2013; 8(3):e58823.
PMID: 23533593
PMC: 3606361.
DOI: 10.1371/journal.pone.0058823.
Sentinel node mapping for breast cancer: current situation.
Vidal-Sicart S, Valdes Olmos R
J Oncol. 2012; 2012:361341.
PMID: 22927845
PMC: 3426254.
DOI: 10.1155/2012/361341.